FDA approves Tenapanor for chronic kidney disease

FDA approves Tenapanor for chronic kidney disease

The FDA approved tenapanor (Xphozah; Ardelyx, Inc.), making it the first and only phosphate absorption inhibitor approved to reduce serum phosphorus in adults with chronic kidney disease (CKD). Hemodialysis as an adjunctive therapy in patients with chronic kidney disease (CKD). who do not respond to phosphate binders or who do not tolerate any dose of … Read more

Research says an easy workout can reduce your risk of heart disease by 20%.

Research says an easy workout can reduce your risk of heart disease by 20%.

Cardio is king when it comes to heart health. There are many different ways you can improve your heart, such as eating the best foods, drinking heart-healthy wine, and adding some cardiologist-approved exercises to your routine. your daily. While you might think the latter means going for a run or going to an aerobics class, … Read more